Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

References for PMC Articles for PubMed (Select 21789790)

1.

Monitoring protein expression in whole-cell extracts by targeted label- and standard-free LC-MS/MS.

Bluemlein K, Ralser M.

Nat Protoc. 2011 Jun;6(6):859-69. doi: 10.1038/nprot.2011.333. Epub 2011 May 26.

PMID:
21637204
2.

Selected reaction monitoring applied to proteomics.

Gallien S, Duriez E, Domon B.

J Mass Spectrom. 2011 Mar;46(3):298-312. doi: 10.1002/jms.1895. Review.

PMID:
21394846
3.

Targeting metabolic remodeling in glioblastoma multiforme.

Wolf A, Agnihotri S, Guha A.

Oncotarget. 2010 Nov;1(7):552-62. Review.

4.

Absolute quantification of protein and post-translational modification abundance with stable isotope-labeled synthetic peptides.

Kettenbach AN, Rush J, Gerber SA.

Nat Protoc. 2011 Feb;6(2):175-86. doi: 10.1038/nprot.2010.196. Epub 2011 Jan 27.

5.

STAT3, HIF-1, glucose addiction and Warburg effect.

Darnell JE Jr.

Aging (Albany NY). 2010 Dec;2(12):890-1. No abstract available.

6.

A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction.

Demaria M, Giorgi C, Lebiedzinska M, Esposito G, D'Angeli L, Bartoli A, Gough DJ, Turkson J, Levy DE, Watson CJ, Wieckowski MR, Provero P, Pinton P, Poli V.

Aging (Albany NY). 2010 Nov;2(11):823-42.

7.

Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz JD, Asara JM, Cantley LC.

Science. 2010 Sep 17;329(5998):1492-9. doi: 10.1126/science.1188015.

8.

Cancer metabolism: the Warburg effect today.

Ferreira LM.

Exp Mol Pathol. 2010 Dec;89(3):372-80. doi: 10.1016/j.yexmp.2010.08.006. Epub 2010 Sep 8. Review.

PMID:
20804748
9.

The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.

Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Witkiewicz AK, Vander Heiden MG, Migneco G, Chiavarina B, Frank PG, Capozza F, Flomenberg N, Martinez-Outschoorn UE, Sotgia F, Lisanti MP.

Cell Cycle. 2010 May 15;9(10):1960-71. Epub 2010 May 15.

10.

Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling".

Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP.

Aging (Albany NY). 2010 Apr;2(4):185-99.

11.

Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.

Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, Lythgoe K, Dong S, Lonial S, Wang X, Chen GZ, Xie J, Gu TL, Polakiewicz RD, Roesel JL, Boggon TJ, Khuri FR, Gilliland DG, Cantley LC, Kaufman J, Chen J.

Sci Signal. 2009 Nov 17;2(97):ra73. doi: 10.1126/scisignal.2000431.

12.

Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.

Spoden GA, Rostek U, Lechner S, Mitterberger M, Mazurek S, Zwerschke W.

Exp Cell Res. 2009 Oct 1;315(16):2765-74. doi: 10.1016/j.yexcr.2009.06.024. Epub 2009 Jun 27.

PMID:
19563799
13.

Cancer cell metabolism: Warburg and beyond.

Hsu PP, Sabatini DM.

Cell. 2008 Sep 5;134(5):703-7. doi: 10.1016/j.cell.2008.08.021.

14.

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.

Mayr JA, Meierhofer D, Zimmermann F, Feichtinger R, Kögler C, Ratschek M, Schmeller N, Sperl W, Kofler B.

Clin Cancer Res. 2008 Apr 15;14(8):2270-5. doi: 10.1158/1078-0432.CCR-07-4131.

15.

Tandem affinity purification combined with mass spectrometry to identify components of protein complexes.

Kaiser P, Meierhofer D, Wang X, Huang L.

Methods Mol Biol. 2008;439:309-26. doi: 10.1007/978-1-59745-188-8_21.

16.

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.

Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC.

Nature. 2008 Mar 13;452(7184):230-3. doi: 10.1038/nature06734.

PMID:
18337823
17.

Pyruvate kinase M2 is a phosphotyrosine-binding protein.

Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC.

Nature. 2008 Mar 13;452(7184):181-6. doi: 10.1038/nature06667.

PMID:
18337815
18.

Pyruvate kinase type M2 and its role in tumor growth and spreading.

Mazurek S, Boschek CB, Hugo F, Eigenbrodt E.

Semin Cancer Biol. 2005 Aug;15(4):300-8. Review.

PMID:
15908230
19.

The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications.

Kirkpatrick DS, Gerber SA, Gygi SP.

Methods. 2005 Mar;35(3):265-73. Epub 2005 Jan 12.

PMID:
15722223
20.

Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma.

Meierhofer D, Mayr JA, Foetschl U, Berger A, Fink K, Schmeller N, Hacker GW, Hauser-Kronberger C, Kofler B, Sperl W.

Carcinogenesis. 2004 Jun;25(6):1005-10. Epub 2004 Feb 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk